Home
About
FAQ
History (40)
MIRO-1 Determines Mitochondrial Shape Transition upon GPCR Activation and Ca2+ Stress.
Combination fusion protein therapy of refractory brain tumors: demonstration of efficacy in cell culture.
Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan: a randomized phase 2 trial by the Cancer and Leukemia Group B (CALGB 19803).
Do statin medications impact renal functional or oncologic outcomes for robot-assisted partial nephrectomy?
Patterns of graft loss following simultaneous kidney-pancreas transplantation.
See All 40 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (838)
More Search Options
Sort
Query Relevance
Name (A-Z)
Name (Z-A)
Institution (A-Z)
Institution (Z-A)
Show
(choose columns)
Faculty Rank
Name
Institution
Why
Sara Jones PhD
Wake Forest School of Medicine
Why?
B. Scott Segal MD, MHCM
Wake Forest School of Medicine
Why?
Roy E. Strowd MD, MEd, MS
Wake Forest School of Medicine
Why?
Jeffrey L. Weiner PhD
Wake Forest School of Medicine
Why?
Michael S. Cartwright MD
Wake Forest School of Medicine
Why?
Osvaldo Delbono MD, PhD
Wake Forest School of Medicine
Why?
Hossam A. Shaltout PhD
Wake Forest School of Medicine
Why?
Glenn J. Lesser MD
Wake Forest School of Medicine
Why?
Ronald L. Davis MD
Wake Forest School of Medicine
Why?
Michael A. Nader PhD
Wake Forest School of Medicine
Why?
Brian A. McCool PhD
Wake Forest School of Medicine
Why?
Debra I. Diz PhD
Wake Forest School of Medicine
Why?
Dwayne W. Godwin PhD
Wake Forest School of Medicine
Why?
Thomas Hollis PhD
Wake Forest School of Medicine
Why?
James C. Eisenach MD
Wake Forest School of Medicine
Why?
Per Page
15
25
50
100
Page
of 56
Next
Prev
Search Criteria
Nervous System
Click "Why?" to see why a person matched the search.
Search Options
Modify Search
Search Other Institutions